FDA Inspection 600975 — Lilly del Caribe, Inc.

Lilly del Caribe, Inc. — FEI 3004525072

The FDA completed an inspection of Lilly del Caribe, Inc. on July 31, 2009 in Carolina, PR. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). 1 citation was issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
July 31, 2009
Fiscal Year
2009
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Carolina, PR (United States)

Citations

IDCFRDescription
202721 CFR 211.192Investigations of discrepancies, failures